Cleared Traditional

K120055 - HANILTON THORNE INFRARED LASER OPTICAL SYSTEM-ZILOS-TK HAMILTON THORNE INFRARED LASER OPTICAL SYSTEM-LYKOS (FDA 510(k) Clearance)

Apr 2012
Decision
106d
Days
Class 2
Risk

K120055 is an FDA 510(k) clearance for the HANILTON THORNE INFRARED LASER OPTICAL SYSTEM-ZILOS-TK HAMILTON THORNE INFRARED LASER OPTICAL SYSTEM-LYKOS. This device is classified as a System, Assisted Reproduction Laser (Class II - Special Controls, product code MRX).

Submitted by Hamilton Thorne, Inc. (Beverly, US). The FDA issued a Cleared decision on April 24, 2012, 106 days after receiving the submission on January 9, 2012.

This device falls under the Obstetrics & Gynecology FDA review panel. Regulated under 21 CFR 884.6200. This System Is Inteded To Be Used To Drill A Small Tangential Hole In Or To Thin The Zona Pellucida Of The Embryo In Selected In Vitro Fertilization Patients With Otherwise Poor Prognois For Successful Pregnancy Outcome, Such As Advanced Maternal Age, Prior Failed In Vitro Fertilization Procedures, Cryopreserved Embryos, Or Abnormal Zona Pellucida Morphology..

Submission Details

510(k) Number K120055 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 09, 2012
Decision Date April 24, 2012
Days to Decision 106 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF

Device Classification

Product Code MRX - System, Assisted Reproduction Laser
Device Class Class II - Special Controls
CFR Regulation 21 CFR 884.6200
Definition This System Is Inteded To Be Used To Drill A Small Tangential Hole In Or To Thin The Zona Pellucida Of The Embryo In Selected In Vitro Fertilization Patients With Otherwise Poor Prognois For Successful Pregnancy Outcome, Such As Advanced Maternal Age, Prior Failed In Vitro Fertilization Procedures, Cryopreserved Embryos, Or Abnormal Zona Pellucida Morphology.